Lauren M Sabella
CIK 1360928 · EVP Operations · last filed 2025-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.28M
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$3.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | EVP Operations | 349,841 | $3.66 | $1.28M | $0 | 9 | 2025-07-17 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Chief Operating Officer | 10,710 | $0.66 | $7.1K | -$3.93M | 38 | 2022-09-07 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | VP of Commercial Development | — | $10.12 | — | $0 | 2 | 2008-02-27 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-05 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −2,429 | -$50.4K | EDGAR |
| 2016-03-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-23 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$142.2K | EDGAR |
| 2015-12-21 | Acorda Therapeutics, Inc. (ACOR) Delisted | Mixed | — | -$255.3K | EDGAR |
| 2015-12-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −7,106 | -$270.5K | EDGAR |
| 2015-03-06 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +6,323 | $0 | EDGAR |
| 2014-12-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −3,242 | -$115.3K | EDGAR |
| 2014-03-07 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2013-12-09 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −8,797 | -$279.8K | EDGAR |
| 2013-12-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −6,603 | -$221.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.